518 related articles for article (PubMed ID: 30506501)
1. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
Haider SA; Lim S; Kalkanis SN; Lee IY
J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review.
Coburger J; Wirtz CR
J Neurooncol; 2019 Feb; 141(3):533-546. PubMed ID: 30488293
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
[TBL] [Abstract][Full Text] [Related]
4. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO; Berger MS
J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
[TBL] [Abstract][Full Text] [Related]
6. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review.
Broekx S; Weyns F; De Vleeschouwer S
Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
Chan DTM; Yi-Pin Sonia H; Poon WS
Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
10. Following the light in glioma surgery: a comparison of sodium fluorescein and 5-aminolevulinic acid as surgical adjuncts in glioma resection.
Navarro-Bonnet J; Suarez-Meade P; Brown DA; Chaichana KL; Quinones-Hinojosa A
J Neurosurg Sci; 2019 Dec; 63(6):633-647. PubMed ID: 31961116
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence-guided surgery for high-grade gliomas.
Lakomkin N; Hadjipanayis CG
J Surg Oncol; 2018 Aug; 118(2):356-361. PubMed ID: 30125355
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence image-guided neurosurgery.
Kaneko S; Eljamel MS
Future Oncol; 2017 Nov; 13(26):2341-2348. PubMed ID: 29121788
[TBL] [Abstract][Full Text] [Related]
13. The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review.
Mansouri A; Mansouri S; Hachem LD; Klironomos G; Vogelbaum MA; Bernstein M; Zadeh G
Cancer; 2016 Aug; 122(16):2469-78. PubMed ID: 27183272
[TBL] [Abstract][Full Text] [Related]
14. Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature.
Suero Molina E; Schipmann S; Stummer W
Neurosurg Rev; 2019 Jun; 42(2):197-208. PubMed ID: 28921173
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up.
Strickland BA; Wedemeyer M; Ruzevick J; Micko A; Shahrestani S; Daneshmand S; Shiroishi MS; Hwang DH; Attenello F; Chen T; Zada G
J Neurosurg; 2022 Nov; 137(5):1378-1386. PubMed ID: 35303704
[TBL] [Abstract][Full Text] [Related]
16. Enhanced resection of primary high-grade gliomas using a combination of intraoperative magnetic resonance imaging and intraoperative fluorescence (5-aminolevulinic acid): A single-centre experience.
Sharma V; Kedia R; Narang KS; Jha AN
Neurol India; 2018; 66(3):747-752. PubMed ID: 29766937
[TBL] [Abstract][Full Text] [Related]
17. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
18. Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.
Morshed RA; Han SJ; Lau D; Berger MS
J Neurosurg; 2018 May; 128(5):1448-1453. PubMed ID: 28665248
[TBL] [Abstract][Full Text] [Related]
19. 5-ALA and FDA approval for glioma surgery.
Hadjipanayis CG; Stummer W
J Neurooncol; 2019 Feb; 141(3):479-486. PubMed ID: 30644008
[TBL] [Abstract][Full Text] [Related]
20. Survival Outcomes Among Patients With High-Grade Glioma Treated With 5-Aminolevulinic Acid-Guided Surgery: A Systematic Review and Meta-Analysis.
Gandhi S; Tayebi Meybodi A; Belykh E; Cavallo C; Zhao X; Syed MP; Borba Moreira L; Lawton MT; Nakaji P; Preul MC
Front Oncol; 2019; 9():620. PubMed ID: 31380272
[No Abstract] [Full Text] [Related]
[Next] [New Search]